Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2016

Open Access 01-12-2016 | Study protocol

Investigating the feasibility and acceptability of a cognitive behavioural suicide prevention therapy for people in acute psychiatric wards (the ‘INSITE’ trial): study protocol for a randomised controlled trial

Published in: Trials | Issue 1/2016

Login to get access

Abstract

Background

Suicide is a major cause of preventable death, and suicidal behaviour is prevalent in acute psychiatric wards. People admitted to acute psychiatric wards often experience repeated episodes of suicidal behaviour, causing great distress and heavy use of NHS services. There is little research investigating effective psychological treatments for suicidal patients in inpatient settings although previous research has found support for psychological therapies which specifically target suicidal behaviour. This paper describes the protocol of a single blind RCT to investigate the acceptability and feasibility of a cognitive behavioural intervention targeting suicidality (CBSP) for suicidal people in acute psychiatric wards.

Methods/Design

A single blind RCT comparing treatment as usual (TAU) to TAU plus Cognitive Behavioural Suicide Prevention (CBSP) therapy (TAU + CBSP). Sixty participants (aged 18–65 years) who are suicidal, or have been within the past 3 months, will be recruited from NHS trusts in the North West of England. Our primary objective is to determine whether CBSP is feasible, acceptable and efficacious when compared to patients who receive TAU alone. Secondary aims are the impact of CBSP on suicidal thinking, behaviours, functioning, quality of life, service use and psychological factors associated with suicide. Assessments take place at baseline, 6 weeks and 6 months (end of treatment). The analysis will report on the feasibility and acceptability of CBSP. Qualitative data from staff and service users will inform feasibility and acceptability data.

Discussion

Psychiatric inpatients are a high-risk group and the use of psychological therapies in these settings is rare and requires evaluation. This study is essential to investigate the unique contextual challenges involved in delivering psychological therapy to suicidal inpatients and to identify any necessary modifications required within inpatient settings. The findings will inform a larger, definitive trial.

Trial registration

15 March 2012, PB-PG-1111-26026, NIHR ISRCTN17890126.
Appendix
Available only for authorised users
Literature
1.
National Confidential Inquiry into Suicide and Homicide by People with Mental Illness (NCISH). Annual report: England, Northern Ireland, Scotland and Wales. July 2015. Manchester: University of Manchester; 2015.
2.
Office for National Statistics. Suicides in the United Kingdom, 2013 Registrations. London: Office for National Statistics; 2015.
3.
Windfuhr K, Kapur N. Suicide and mental illness: a clinical review of 15 years findings from the UK National Confidential Inquiry into Suicide. Brit Med Bull. 2011;100:101.CrossRefPubMed
4.
National Confidential Inquiry into Suicide and Homicide by People with Mental Illness (NCISH). Suicide in primary care in England: 2002–2011. Manchester: University of Manchester; 2014.
5.
Hunt IM, Kapur N, Webb R, Robinson J, Burns J, Turnbull P, et al. Suicide in current psychiatric in-patients: a case-control study. Psychol Med. 2007;37:831–37.CrossRefPubMed
6.
Bickley H, Hunt IM, Windfuhr K, Shaw J, Appleby L, Kapur N. Suicide within two weeks of discharge from psychiatric inpatient care: a case-control study. Psych Serv. 2013;64:653–59.CrossRef
7.
Knapp M, McDaid D, Personage M. Mental health promotion and prevention: the economic case. A report by Personal Social Services Research Unit, London School of Economics and Political Science, Department of Health. 2011.
8.
Health & Social Care Information Centre. Mental health bulletin: annual report from MHMDS Returns 2013–14. November 2014.
9.
Haw C, Bergen H, Casey D, Hawton K. Repetition of deliberate self‐harm: a study of the characteristics and subsequent deaths in patients presenting to a general hospital according to extent of repetition. Suic Life-Threat Behav. 2007;37:379–96.CrossRef
10.
Kapur N, Cooper J, King-Hele S, Webb R, Lawlor M, Rodway C, et al. The repetition of suicidal behaviour: a multicenter cohort study. J Clin Psychiatr. 2006;67:1599–609.CrossRef
11.
Royal College of Psychiatrists. Second round of the National Audit of Psychological Therapies for Anxiety and Depression (NAPT). 2013.
12.
Care Quality Commission. Right here, right now: people’s experiences of help, care and support during a mental health crisis. London: Care Quality Commission; 2015.
13.
The Schizophrenia Commission. The abandoned illness: a report from the Schizophrenia Commission. London: Rethink Mental Illness; 2012.
14.
Johnson S, Paul SW, Osborn D, Wearn E, Lloyd-Evans B, Totman J, et al. Inpatient mental health staff morale: a national investigation. London: NIHR Service Delivery and Organisation programme; 2011.
15.
National Institute for Health and Clinical Excellence (NICE). Self-harm. Longer term management. London: CG133; 2011.
16.
Tarrier N, Taylor K, Gooding P. Cognitive-behavioral interventions to reduce suicide behavior: A systematic review and meta-analysis. Behav Modif. 2008;32:77–108.CrossRefPubMed
17.
Tarrier N, Kelly J, Maqsood S, Snelson N, Maxwell J, Law H, et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophr Res. 2014;156:204–10.CrossRefPubMed
18.
Chang NA, Stanley B, Brown GK, Cunningham A. Treating the suicidal patient: cognitive therapy and dialectical behaviour therapy. In: O’Connor RC, Platt S, Gordon J, editors. International handbook of suicide prevention: research, policy and practice. Chichester: Wiley; 2011.
19.
Tarrier N, Gooding P, Pratt D, Kelly J, Awenat Y, Maxwell J. Cognitive behavioural prevention of suicide in psychosis: a treatment manual. London: Routledge; 2013.
20.
21.
Johnson J, Gooding P, Tarrier N. Suicide risk in schizophrenia: explanatory models and clinical implications, The Schematic Appraisal Model of Suicide (SAMS). Psychol Psychother Theory Res Pract. 2008;81:55–77.CrossRef
22.
23.
Haddock G, Devane S, Bradshaw TJ, McGovern J, Tarrier N, Kinderman P, et al. An investigation into the psychometric properties of the cognitive therapy scale of psychosis (CTS-Psy). Behav Cog Psychother. 2001;29:221–33.CrossRef
24.
Beck A, Kovacs M, Weissman A. Assessment of suicidal intention: The Scale of Suicide Ideation. J Consult Clin Psychol. 1979;47:343.CrossRefPubMed
25.
Osman A, Bagge CL, Gutierrez PM, Konick LC, Kopper BA, Barrios FX. The Suicidal Behaviors Questionnaire-Revised (SBQ-R): Validation with clinical and nonclinical samples. Assessment. 2001;8:443–54.CrossRefPubMed
26.
Cull J, Gill W. Suicide probability scale. Western Psychological Services, Los Angeles. CA The Suicide Probability Scale is a proprietary instrument published by Western Psychological Services. 1982;12031:1997–2005.
27.
Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: The Hopelessness Scale. J Consult Clinl Psychol. 1974;42:861.CrossRef
28.
Steed L. Further validity and reliability evidence for Beck Hopelessness Scale scores in a nonclinical sample. Edu Psychol Measur. 2001;61:303–16.CrossRef
29.
Kay SR, Flszbein A, Opfer LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261.CrossRefPubMed
30.
Peralta V, Cuesta MJ. Psychometric properties of the Positive and Negative Syndrome Scale (PANSS) in schizophrenia. Psychiatr Res. 1994;53:31–40.CrossRef
31.
Haddock G, McCarron J, Tarrier N, Faragher E, Tarrier N. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med. 1999;29:879–89.CrossRefPubMed
32.
Addington D, Addington J, Schissel B. A depression rating scale for schizophrenics. Schizophr Res. 1990;3:247–51.CrossRefPubMed
33.
Addington J, Shah H, Liu L, Addington D. Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis. Schizophr Res. 2014;153:64–7.PubMedCentralCrossRefPubMed
34.
Espie C, Kyle S, Hames P, Gardani M, Fleming L, Cape J. The Sleep Condition Indicator (SCI): a practical clinical screening tool to evaluate DSM-5 insomnia disorder. Sleep. 2013;36(Suppl):A193–4.
35.
Morosini PL, Magliano L, Brambilla L, Ugolini S, Pioli R. Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand. 2000;101:323–29.PubMed
36.
Kawaka AK, Ravicki DA. Psychometric properties of the Personal and Social Performance scale (PSP) among individuals with schizophrenia living in the community. Qual Life Res. 2008;17:1247–56.CrossRef
37.
Group W. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28:551–8.CrossRef
38.
Skevington SM, Lotfy M, O’Connel KA. The World Health Organization’s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A Report from the WHOQOL Group. Qual Life Res. 2004;13:299–310.CrossRefPubMed
39.
Gilbert P, Allan S. The role of defeat and entrapment (arrested flight) in depression: an exploration of an evolutionary view. Psychol Med. 1998;28:585–98.CrossRefPubMed
40.
Robson P. Development of a new self-report questionnaire to measure self esteem. Psychol Med. 1989;19:513–18.CrossRefPubMed
41.
Ghaderi A. Psychometric properties of the self-concept questionnaire. Eur J Psychol Assess. 2005;21:139–46.CrossRef
42.
Endler N, Parker J. Coping Inventory for Stressful Situations (CISS): manual. Toronto: Multi-Health Systems; 1990.
43.
McWilliams LA, Cox BJ, Enns MW. Use of the coping inventory for stressful situations in a clinically depressed sample: factor structure, personality correlates, and prediction of distress. J Clin Psych. 2003;59:423–37.CrossRef
44.
Evans J, Rose D, Flach C, Csipke E, Glossop H, McCrone P, et al. VOICE: developing a new measure of service users’ perceptions of inpatient care, using a participatory methodology. J Ment Health. 2012;21:57–71.PubMedCentralCrossRefPubMed
45.
Laker C, Rose D, Flach C, Csipke E, McCrone P, Craig T, et al. Views of the Therapeutic Environment (VOTE): stakeholder involvement in measuring staff perceptions of acute in-patient care. Internat J Nurs Stud. 2012;49:1403–10.CrossRef
46.
47.
Dolan P, Gudex C, Kind P, Williams A. A social tariff for EuroQol: results from a UK general population survey. UK: Centre for Health Economics University of York; 1995.
48.
Horvath AO, Greenberg LS. Development and validation of the Working Alliance Inventory. J Couns Psychol. 1989;36:223–33.CrossRef
49.
50.
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101.CrossRef
Metadata
Title
Investigating the feasibility and acceptability of a cognitive behavioural suicide prevention therapy for people in acute psychiatric wards (the ‘INSITE’ trial): study protocol for a randomised controlled trial
Publication date
01-12-2016
Published in
Trials / Issue 1/2016
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-016-1192-9

Other articles of this Issue 1/2016

Trials 1/2016 Go to the issue

Study protocol

START NOW - a comprehensive skills training programme for female adolescents with oppositional defiant and conduct disorders: study protocol for a cluster-randomised controlled trial

Research

Representativeness of the participants in the smoking Cessation in Pregnancy Incentives Trial (CPIT): a cross-sectional study

Study protocol

Lapatinib-capecitabine versus capecitabine alone as radiosensitizers in RAS wild-type resectable rectal cancer, an adaptive randomized phase II trial (LaRRC trial): study protocol for a randomized controlled trial

Study protocol

Efficacy and safety of auricular point acupressure treatment for gastrointestinal dysfunction after laparoscopic cholecystectomy: study protocol for a randomized controlled trial

Study protocol

Efficacy of bone substitute material in preserving volume when placing a maxillary immediate complete denture: study protocol for the PANORAMIX randomized controlled trial

Study protocol

Acetyl-L-carnitine (ALCAR) to enhance nerve regeneration in carpal tunnel syndrome: study protocol for a randomized, placebo-controlled trial